Identification of PSMB5 as a genetic modifier of fragile X–associated tremor/ataxia syndrome
Ha Eun Kong,Junghwa Lim,Alexander Linsalata,Yunhee Kang,Indranil Malik,Emily G. Allen,Yiqu Cao,Lisa Shubeck,Rich Johnston,Yanting Huang,Yanghong Gu,Xiangxue Guo,Michael E. Zwick,Zhaohui Qin,Thomas S. Wingo,Jorge Juncos,David L. Nelson,Michael P. Epstein,David J. Cutler,Peter K. Todd,Stephanie L. Sherman,Stephen T. Warren,Peng Jin
DOI: https://doi.org/10.1073/pnas.2118124119
IF: 11.1
2022-05-26
Proceedings of the National Academy of Sciences
Abstract:Significance Expansion of 55-200 CGG repeats in the 5′ untranslated region of FMR1 predisposes carriers to fragile X–associated tremor/ataxia syndrome (FXTAS), a late-onset neurodegenerative disorder. FXTAS demonstrates incomplete penetrance, which strongly suggests the presence of genetic modifiers. We performed whole-genome sequencing (WGS) on male premutation carriers (CGG 55–200 ) followed by a functional screen in Drosophila and identified PSMB5 as a strong suppressor of CGG-associated neurodegeneration, thereby presenting a therapeutic strategy for FXTAS.
multidisciplinary sciences
What problem does this paper attempt to address?